We are live on
!
Find out more
AstraZeneca
AZN
AZN
603 hedge funds and large institutions have $19.8B invested in AstraZeneca in 2020 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 196 increasing their positions, 223 reducing their positions, and 85 closing their positions.
New
Increased
Maintained
Reduced
Closed
30% more funds holding in top 10
Funds holding in top 10: 10 → 13 (+3)
0.18% less ownership
Funds ownership: 17.03% → 16.85% (-0.18%)
2% less call options, than puts
Call options by funds: $88.9M | Put options by funds: $90.8M
5% less funds holding
Funds holding: 633 → 603 (-30)
11% less capital invested
Capital invested by funds: $22.3B → $19.8B (-$2.53B)
12% less repeat investments, than reductions
Existing positions increased: 196 | Existing positions reduced: 223
28% less first-time investments, than exits
New positions opened: 61 | Existing positions closed: 85
Holders
603
Holders Change
-30
Holders Change %
-4.74%
% of All Funds
13.29%
Holding in Top 10
13
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+30%
% of All Funds
0.29%
New
61
Increased
196
Reduced
223
Closed
85
Calls
$88.9M
Puts
$90.8M
Net Calls
-$1.9M
Net Calls Change
-$33.7M
Top Buyers
| 1 |
Capital International Investors
Los Angeles,
California
|
+$253M |
| 2 |
Renaissance Technologies
New York
|
+$138M |
| 3 |
BlackRock
New York
|
+$104M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$102M |
| 5 |
Jennison Associates
New York
|
+$101M |
